tocophersolan has been researched along with Alloxan Diabetes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Adu-Frimpong, M; He, Q; Ji, H; Li, X; Rong, W; Shen, X; Shi, F; Toreniyazov, E; Wang, Q; Xia, X; Xu, X; Yu, J; Zhang, J | 1 |
Han, S; Mutlu-Agardan, NB | 1 |
Balasubramanian, S; Malathi, S; Nandhakumar, P; Pandiyan, V; Webster, TJ | 1 |
3 other study(ies) available for tocophersolan and Alloxan Diabetes
Article | Year |
---|---|
Preparation,
Topics: Animals; Biological Availability; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Liposomes; Mice; Particle Size; Polyethylene Glycols | 2022 |
Topics: Administration, Oral; Animals; Blood Glucose; Deoxycholic Acid; Diabetes Mellitus, Experimental; Drug Carriers; Drug Delivery Systems; Drug Liberation; Hypoglycemic Agents; Insulin; Liposomes; Male; Nanoparticles; Particle Size; Phospholipids; Rats; Rats, Wistar; Vitamin E | 2021 |
Novel PLGA-based nanoparticles for the oral delivery of insulin.
Topics: Administration, Oral; alpha-Tocopherol; Animals; Diabetes Mellitus, Experimental; Drug Carriers; Emulsions; Glucose; Insulin; Lactic Acid; Male; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Vitamin E | 2015 |